BioFocus Renews French Research Tax Credit Accreditation
News Jun 09, 2010
BioFocus has announced that it had been notified by the French Ministry of Higher Education and Research, that its CIR accreditation had been renewed.
The accreditation allows eligible French companies to benefit from significant tax relief (Crédit d'Impôt sur la Recherche) on research carried out by BioFocus on their behalf until 2013. The accreditation is an extension of the current agreement, in place since 2008, covering work at both UK and The Netherlands research facilities.
“The renewal of our CIR accreditation allows our eligible clients the opportunity to receive 30% of their R&D costs in tax credits” said Richard Gordon, Senior Director, Sales and Marketing. “Clients who have benefited from this facility over the last three years can continue to do so and access BioFocus’ evolving discovery platform”.
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019